Until now, high levels of GH and IGF-1, the persistence of active acromegaly despite therapies, the untreated hypogonadism, the overtreated central hypoadrenalism were recognized as risk factors for skeletal fragility in acromegaly [7, 20–27]. The gene discussed is IGF1; the disease is hypogonadism.